ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    Piromelatine
Previous Study | Return to List | Next Study

Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02615002
Recruitment Status : Recruiting
First Posted : November 25, 2015
Last Update Posted : April 11, 2018
Sponsor:
Information provided by (Responsible Party):
Neurim Pharmaceuticals Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : April 2019
  Estimated Study Completion Date : April 2019